Skip to main content
logo
Can-Fite BioPharma Ltd. (TLV:CANF)
Israel flag Israel · Delayed Price · Currency is ILS · Price in ILA
341.50
-4.80 (-1.39%)
Sep 10, 2026, 5:24 PM IDT

Can-Fite BioPharma Ratios and Metrics

Millions ILS. Fiscal year is Jan - Dec.

Total Valuation

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Market Capitalization
1579573269120
Market Cap Growth
-68.64%38.59%77.98%-53.52%-42.86%29.93%
Enterprise Value
-6573923076
Last Close Price
3.4630.0057.0078.00252.00441.00

Price Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Forward PE
-3.943.943.943.9417.82
PS Ratio
12.3060.8423.0911.9024.0645.20
PB Ratio
1.034.412.861.424.362.68
P/TBV Ratio
1.034.412.861.424.362.68

EV Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
EV/Sales Ratio
-44.2315.920.6510.6328.70

Financial Efficiency

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Debt / Equity Ratio
0.010.010.020.010.010.01
Net Debt / Equity Ratio
-1.44-1.51-1.43-1.42-1.77-1.32
Net Debt / EBITDA Ratio
0.720.850.961.090.791.48
Net Debt / FCF Ratio
0.740.951.021.050.731.93
Asset Turnover
0.050.040.070.080.060.06
Quick Ratio
3.173.133.844.423.197.01
Current Ratio
3.603.464.384.913.667.35
Return on Equity (ROE)
-211.37%-178.24%-134.94%-142.49%-107.91%-123.34%
Return on Assets (ROA)
-77.12%-66.75%-53.18%-53.15%-42.73%-53.91%
Return on Capital Employed (ROCE)
-166.90%-146.70%-115.00%-102.80%-148.90%-73.30%

Yields

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Earnings Yield
-191.78%-39.89%-50.64%-86.33%-52.20%-32.72%
FCF Yield
-190.98%-36.33%-49.11%-95.47%-55.47%-25.60%
Buyback Yield / Dilution
-196.15%-126.97%-70.22%-56.71%-47.49%-54.32%